Live News Categoriesmarket

TRVI.O (TRVI.O) News

Follow TRVI.O (TRVI.O) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol TRVI.O Asset market Sector Markets 90 days 1 Updated Oct 13, 2026, 11:36 AM UTC Open live news feed

L Trevi Therapeutics says Phase 2b CORAL trial results accepted for oral presentation at CHEST 2026 Trevi Therapeutics announced Phase 2b CORAL trial results on oral nalbuphine ER were accepted for a future CHEST 2026 oral presentation. The data will be presented Oct. 20 at the CHEST 2026 Annual Meeting in Phoenix. Pat NEWS | Oct 13, 2026, 11:36 AM UTC